28Mar 2024
Novocure's Tumor Treating Fields Device Shows Promise in Slowing Lung Cancer Spread to Brain

Novocure's Tumor Treating Fields Device Shows Promise in Slowing Lung Cancer Spread to Brain

Novocure announced today that its Tumor Treating Fields device successfully achieved the primary objective in a late-stage trial by impeding the progression of cancer to the brain in patients with non-small cell lung cancer (NSCLC). The device, used in conjunction with standard systemic therapies and supportive care, extended the duration before cancer spread to the brain to 21.9 months, compared to 11.3 months with supportive care alone. Novocure disclosed that approximately a quarter of NSCLC patients experience brain metastasis at diagnosis. The company intends to submit the trial data to regulatory bodies following this promising outcome

  • #oncology

Like

Save

Share